SummarySystemic gaps, ranging from limited diagnostic access to unevenly distributed treatment centers, continue to restrict access to regular replacement therapy (RRT), especially beyond metro cities in India. In contrast, more than 50 per cent of persons with hemophilia globally benefit from RRT as the standard of care.